Use of Daratumumab in Patients With Previously Treated Multiple Myeloma

被引：0
|
作者：
Patel, Ashwin P. [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 14期
关键词：
D O I：
10.1200/JCO.22.02850
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Response to daratumumab-retreatment in patients with multiple myeloma
    Souren, Laura
    Ihorst, Gabriele
    Greil, Christine
    Engelhardt, Monika
    Waesch, Ralph
    ANNALS OF HEMATOLOGY, 2024, : 1059 - 1067
  • [32] Effect of amplification or gain of 1Q21 in patients with multiple myeloma treated with daratumumab
    Zamanillo, Irene
    Medina de Alba, Lucia
    Alonso, Rafael
    Maria Sanchez, Jose
    Cuellar, Clara
    Fernandez-Guijarro, Manuela
    Martinez-Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S235 - S236
  • [33] Daratumumab reactivates resolved HBV in patients with multiple myeloma
    Reactions Weekly, 2021, 1852 (1) : 10 - 10
  • [34] EDA-V in advanced multiple myeloma patients previously treated with thalidomide
    Polloni, C.
    Offidani, M.
    Corvatta, L.
    Piersantelli, M. N.
    Catarini, M.
    Brunori, M.
    Alesiani, F.
    Burattini, M.
    Leoni, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 145 - 146
  • [35] A US Cost Analysis of Triplet Regimens for Patients with Previously Treated Multiple Myeloma
    Hollmann, Sarah
    Moldaver, Daniel
    Goyert, Nik
    Grima, Daniel
    Maiese, Eric M.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (04): : 449 - 459
  • [36] POMALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PREVIOUSLY TREATED WITH LENALIDOMIDE
    Gomez, Hernando Marta
    Gironella, Merce
    Abella, Eugenia
    Cabezudo, Elena
    Motllo, Cristina
    Garcia, Antoni
    Sarra, Josep
    Mostacedo, Silvia
    Granell, Miquel
    Rosinol, Laura
    HAEMATOLOGICA, 2020, 105 : 13 - 14
  • [37] Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysis
    Wang, Jiasheng
    Kim, Yeseong
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (05) : 650 - 657
  • [38] Daratumumab-induced in vivo immune modulation in relapsed and/refractory multiple myeloma patients treated with daratumumab-len-dex
    Giannotta, Claudia
    Ziccheddu, Bachisio
    D'Agostino, Mattia
    Bertuglia, Giuseppe
    Saraci, Elona
    Oliva, Stefania
    Bolli, Niccolo'
    Landgren, Ola
    Bruno, Benedetto
    Boccadoro, Mario
    Maura, Francesco
    Massaia, Massimo
    Larocca, Alessandra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S256 - S257
  • [39] ACCELERATED INFUSION OF DARATUMUMAB IS SAFE IN MULTIPLE MYELOMA PATIENTS
    Jak, M.
    Oostvogels, R.
    Minnema, M. C.
    HAEMATOLOGICA, 2018, 103 : 20 - 20
  • [40] Home-Based Daratumumab in Patients With Multiple Myeloma
    Rosenberg, Tine
    Kirkegaard, Jannie
    Gundesen, Michael Tveden
    Rasmussen, Maja Kjaer
    Dieperink, Karin Brochstedt
    Lund, Thomas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
12345